Advertisement
UK markets closed
  • FTSE 100

    8,075.71
    +35.33 (+0.44%)
     
  • FTSE 250

    19,591.15
    -128.22 (-0.65%)
     
  • AIM

    752.90
    -1.79 (-0.24%)
     
  • GBP/EUR

    1.1657
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2495
    +0.0033 (+0.26%)
     
  • Bitcoin GBP

    51,074.87
    -572.32 (-1.11%)
     
  • CMC Crypto 200

    1,377.82
    -4.75 (-0.34%)
     
  • S&P 500

    5,009.99
    -61.64 (-1.22%)
     
  • DOW

    37,850.24
    -610.68 (-1.59%)
     
  • CRUDE OIL

    82.28
    -0.53 (-0.64%)
     
  • GOLD FUTURES

    2,343.30
    +4.90 (+0.21%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,923.79
    -164.91 (-0.91%)
     
  • CAC 40

    8,020.23
    -71.63 (-0.89%)
     

Why Novavax Stock Slipped on Thursday

Why Novavax Stock Slipped on Thursday

The departing party is Greg Glenn, the president of research and development. First, research and development is a crucial area for biotechs like Novavax, as their future is heavily dependent on their pipeline programs. Second, Glenn was a longtime company mainstay, having joined Novavax in 2010.